Elevated plasma D-dimer levels correlate with long term survival of gastric cancer patients

PLoS ONE

Volumn 9, Issue 3, 2014, Pages

  Liu, Long ^a   Zhang, Xi ^b   Yan, Bing ^c   Gu, Qunhao ^d   Zhang, Xiaodong ^d   Jiao, Jianpeng ^c   Sun, Dazhi ^c   Wang, Ning ^a   Yue, Xiaoqiang ^a  

^a SECOND MILITARY MEDICAL UNIVERSITY   (China)

^b SECOND MILITARY MEDICAL UNIVERSITY   (China)

^c SECOND MILITARY MEDICAL UNIVERSITY   (China)

^d SHANGHAI UNIVERSITY OF TRADITIONAL CHINESE MEDICINE   (China)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; D DIMER; FIBRIN DEGRADATION PRODUCT; FIBRIN FRAGMENT D;

ADULT; ARTICLE; CANCER STAGING; CANCER SURVIVAL; CONTROLLED STUDY; DISEASE ASSOCIATION; DISTANT METASTASIS; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FOLLOW UP; HUMAN; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; OVERALL SURVIVAL; PROTEIN BLOOD LEVEL; STOMACH CANCER; SURVIVAL TIME; TUMOR INVASION; TUMOR VOLUME; UPREGULATION; AGED; BLOOD; METABOLISM; METASTASIS; MIDDLE AGED; MORTALITY; PERITONEAL NEOPLASMS; PROGNOSIS; RECEIVER OPERATING CHARACTERISTIC; SECONDARY; STOMACH NEOPLASMS;

AGED; BIOLOGICAL MARKERS; FEMALE; FIBRIN FIBRINOGEN DEGRADATION PRODUCTS; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; NEOPLASM METASTASIS; NEOPLASM STAGING; PERITONEAL NEOPLASMS; PROGNOSIS; ROC CURVE; STOMACH NEOPLASMS; TUMOR BURDEN;

EID: 84897478711     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0090547     Document Type: Article

References (32)

1. Jemal A, Bray F, Center MM, Ferlay J, Ward E, et al. (2011) Global cancer statistics. CA Cancer J Clin 61: 69-90.
2. Liu Y, Zhang Q, Ren C, Ding Y, Jin G, et al. (2012) A germline variant N375S in MET and gastric cancer susceptibility in a Chinese population. J Biomed Res 26: 315-318.
3. Correa P (1992) Human gastric carcinogenesis: a multi-step and multifactorial process, first American cancer society award lecture on cancer epidemiology and prevention. Cancer Res 52: 6735-6740.
4. Tatsuta M, Iishi H, Nakaizumi A, Okuda S, Taniguchi H, et al. (1993) Fundal atrophic gastritis as a risk factor for gastric cancer. Int J Cancer 53:70-74. (Pubitemid 23018425)
5. Yonemura Y, Bandou E, Kawamura T, Endou Y, Sasaki T (2006) Quantitative prognostic indicators of peritoneal dissemination of gastric cancer. Eur J Surg Oncol 32: 602-606. (Pubitemid 44063992)
6. Kamangar F, Dores GM, Anderson WF (2006) Patterns of cancer incidence, mortality, and prevalence across five continents: defining priorities to reduce cancer disparities in different geographic regions of the world. J Clin Oncol 24: 2137-2150. (Pubitemid 46655601)
7. Wagner AD, Grothe W, Haerting J, Kleber G, Grothey A, et al. (2006) Chemotherapy in advanced gastric cancer: a systematic review and meta-analysis based on aggregate data. J Clin Oncol 24: 2903-2909. (Pubitemid 46630593)
8. Bick RL (1992) Coagulation abnormalities in malignancy: a review. Semin Thromb Hemost 18: 353-372.
9. Luzzatto G, Schafer Al (1990) The prethrombotic state in cancer. Semin Oncol 17: 147-159.
10. Sun D, Liu L, Jiao JP, Wei PK, Jian LD, et al. (2010). Syndrome characteristics of traditional Chinese medicine:summary of a clinical survey in 767 patients with gastric cancer. J Chinese Integr Med 4: 332-340.
11. Yamashita H, Kitayama J, Nagawa H (2005) Hyperfibrinogenemia is a useful predictor for lymphatic metastasis in human gastric cancer. Jpn J Clin Oncol 35: 595-600. (Pubitemid 41662696)
12. Fidan E, Kavgaci H, Orem A, Yilmaz M, Yildiz B (2012) Thrombin activatable fibrinolysis inhibitor and thrombin-antithrombin-III-complex levels in patients with gastric cancer. Tumour Biol 33: 1519-1525.
13. Ay C, Dunkler D, Pirker R, Thaler J, Quehenberger P (2012) High D-dimer levels are associated with poor prognosis in cancer patients. Haematologica 97: 1158-1164.
14. Kwon HC, Oh SY, Lee S, Kim SH, Han JY, et al. (2009) Plasma levels of prothrombin fragment F1+2, D-dimer and prothrombin time correlate with clinical stage and lymph node metastasis in operable gastric cancer patients. Jpn J Clin Oncol 27: 4124-4129.
15. Dupuy E, Hainaud P, Villemain A, Bodevin-Phèdre E, Brouland JP, et al. (2003) Tumoral angiogenesis and tissue factor expression during hepatocellular carcinoma progression in a transgenic mouse model. J Hepatol 38: 793-802. (Pubitemid 36613346)
16. Buller HR, van Doormaal FF, van Sluis GL, Kamphuisen PW (2007) Cancer and thrombosis: From molecular mechanisms to clinical presentations. J Thromb Haemost 5: 246-254. (Pubitemid 46958840)
17. Trotti A, Fritz AG, Compton CC, Byrd DR, Greene FL, et al. (2009) AJCC cancer staging manual. 7th ed. New York: Springer-Verlag, 117-126.
18. Xu G, Wu ZJ, Jiang P (2005) Relationship between pre- and post operative plasma D-dimer levels and clinicopathologic factors in gastric cancer patients. Prac J Med Pharm 22: 977-978.
19. Buccheri G, Torchio P, Ferrigno D (2003) Plasma levels of D-dimer in lung carcinoma. Cancer 97: 3044-3052.
20. Altiay G, Ciftci A, Demir M, Kocak Z, Sut N, et al. (2007) High plasma D-dimer level is associated with decreased survival in patients with lung cancer. Clin Oncol 19: 494-498. (Pubitemid 47181178)
21. Unsal E, Atalay F, Atikcan S, Y?lmaz A (2004) Prognostic significance of hemostatic parameters in patients with lung cancer. Resp Med 98: 93-98. (Pubitemid 38181125)
22. Seitz R, Rappe N, Kraus M, Immel A, Wolf M, et al. (1993) Activation of coagulation and fibrinolysis in patients with lung cancer: relation to tumor stage and prognosis. Blood Coagul Fibrinolysis 4: 249-254. (Pubitemid 23103801)
23. Wang Y, Wang YT, Lin YH, Zou ZD, et al. (2009) Effects of Xuesaitong injection on coagulation function of gastric cancer patients undergoing laparoscopic surgery: a randomized controlled trial. J Chinese Integr Med 7: 514-517.
24. Kwon HC, Oh SY, Lee S, Kim SH, Han JY, et al. (2008) Plasma levels of prothrombin fragment F1+2, D-dimer and prothrombin time correlate with clinical stage and lymph node metastasis in operable gastric cancer patients. Jpn J Clin Oncol 38: 2-7. (Pubitemid 351248114)
25. Ahn HS, Shin YS, Park PJ, Kang KN, Kim Y, et al. (2012) Serum biomarker panels for the diagnosis of gastric adenocarcinoma. Br J Cancer 106:733-739.
26. Blackwell K, Hurwitz H, Liebérman G, Novotny W, Snyder S, et al. (2004) Circulating D-dimer levels are better predictors of overall survival and disease progression than carcinoembryonic antigen levels in patients with metastatic colorectal carcinoma. Cancer 101: 77-82. (Pubitemid 38812425)
27. Gadducci A, Cosio S, Tana R, Genazzani AR (2009) Serum and tissue biomarkers as predictive and prognostic variables in epithelial ovarian cancer. Crit Rev Oncol Hematol 69: 12-27.
28. Tas F, Ciftci R, Kilic L, Serilmez M, Karabulut S (2013) Clinical and Prognostic Significance of Coagulation Assays in Gastric Cancer. J Gastrointest Cancer 44: 285-292.
29. Yigit E, Gönüllü G, Yücel I, Turgut M, Erdem D, et al. (2008) Relation between hemostatic parameters and prognostic/predictive factors in breast cancer. Eur J Intern Med 19: 602-607.
30. Ke B, Wu LL, Liu N, Zhang RP, Wang CL (2013) Overexpression of stathmin1 is associated with poor prognosis of patient with gastric cancer. Tumor Biol 34: 3137-3145.
31. Hajjari M, Behmanesh M, Sadeghizadeh M, Zeinoddini M (2013) Upregulation of HOTAIR long non-coding RNA in human gastric adenocarcinoma tissues. Med Oncol 30: 670.
32. Mei D, Song H, Wang K, Lou Y, Sun W, et al. (2013) Up-regulation of SUMO1 pseudogene 3 (SUMO1P3) in gastric cancer and its clinical association. Med Oncol 30: 709.